# Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)

> **NCT01528501** · PHASE2 · TERMINATED · sponsor: **Technical University of Munich** · enrollment: 28 (estimated)

## Conditions studied

- Metastatic Gastric Cancer

## Interventions

- **DRUG:** Panobinostat (LBH589)

## Key facts

- **NCT ID:** NCT01528501
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 28 (ESTIMATED)
- **Why stopped:** medical/ethical reasons
- **Last updated:** 2013-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528501, "Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01528501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*